Telomere Maintenance Mechanisms in Liposarcomas: Association with Histologic Subtypes and Disease Progression
Open Access
- 1 September 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (17), 8918-8924
- https://doi.org/10.1158/0008-5472.can-06-0273
Abstract
Human cancer cells maintain telomeres by telomerase activity (TA) or by alternative lengthening of telomeres (ALT). We proposed to define the prevalence of the two telomere maintenance mechanisms (TMM), to assess their association with histology, and to compare their prognostic relevance in a series of 93 patients with liposarcoma. ALT was detected by assaying ALT-associated promyelocytic leukemia nuclear bodies and TA was assayed using the telomeric repeat amplification protocol. ALT or TA was found in 25.9% or 26.6% of 139 tested liposarcoma lesions, respectively. Three lesions were ALT+/TA+ whereas ∼50% of lesions did not show any known TMM. TMM phenotype was consistent during disease progression. ALT was prevalent in dedifferentiated and in grade 3 liposarcomas whereas TA prevailed in most round-cell myxoid and in grade 2 liposarcomas. ALT and TA incidence was similar in primary and recurrent lesions whereas metastases were more frequently TA+ than ALT+ (59% versus 18%; P = 0.04). TMM presence negatively affected patient prognosis (P = 0.001): increased mortality was associated with positivity for TA (P = 0.038) or ALT (P < 0.0001) compared with TMM absence. ALT proved to be a stronger prognostic discriminant of increased mortality than TA even when adjusted for tumor location, grade, and histology (hazard ratio for cause-specific death, 3.58 versus 1.15). Our results indicate that ALT can support fully malignant liposarcomas and is associated with unfavorable disease outcome. (Cancer Res 2006; 66(17): 8918-24)Keywords
This publication has 36 references indexed in Scilit:
- Immortal ALT+ Human Cells Do Not Require Telomerase Reverse Transcriptase for Malignant TransformationCancer Research, 2005
- From stem cells to cancer: balancing immortality and neoplasiaOncogene, 2004
- Retroperitoneal soft tissue sarcomasCancer, 2004
- Alternative lengthening of telomeres: dangerous road less travelledThe Lancet, 2003
- Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progressionGenes & Development, 2003
- Alternative lengthening of telomeres in mammalian cellsOncogene, 2002
- Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomasOncogene, 2001
- Coexistence of Alternative Lengthening of Telomeres and Telomerase in hTERT-Transfected GM847 CellsMolecular and Cellular Biology, 2001
- Telomere Shortening Is Associated with Cell Division in Vitro and in VivoExperimental Cell Research, 1995
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994